RBF Capital’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Hold |
28,253
| – | – | 0.01% | 544 |
|
|
2025
Q1 | $138K | Hold |
28,253
| – | – | 0.01% | 519 |
|
|
2024
Q4 | $190K | Buy |
28,253
+1
| +0% | +$7 | 0.01% | 498 |
|
|
2024
Q3 | $218K | Hold |
28,252
| – | – | 0.01% | 533 |
|
|
2024
Q2 | $170K | Buy |
+28,252
| New | +$170K | 0.01% | 524 |
|
|
2021
Q2 | – | Sell |
-1,215
| Closed | -$72K | – | 493 |
|
|
2021
Q1 | $72K | Sell |
1,215
-4,100
| -77% | -$243K | ﹤0.01% | 439 |
|
|
2020
Q4 | $277K | Hold |
5,315
| – | – | 0.02% | 322 |
|
|
2020
Q3 | $257K | Hold |
5,315
| – | – | 0.03% | 294 |
|
|
2020
Q2 | $275K | Hold |
5,315
| – | – | 0.03% | 304 |
|
|
2020
Q1 | $232K | Sell |
5,315
-3,630
| -41% | -$158K | 0.03% | 300 |
|
|
2019
Q4 | $359K | Buy |
+8,945
| New | +$359K | 0.03% | 284 |
|